- Induction of ovulation & pregnancy in infertile women with secondary anovulation who have been appropriately pretreated with menotropins/FSH:
- IM 5,000-10,000 units *1
- Give 1 day after last follicle stimulating agent dose
- Male hypogonadotropic hypogonadism:
- IM 500-4,000 units 2-3 times/week (may require 2-3 months of therapy)
- Dose is individualized
- If needed, add follitropin alfa or menopausal gonadotropin to induce spermatogenesis
- Continue hCG therapy at dose required to maintain testosterone levels
- Induction of spermatogenesis (Off-label):
- Initially IM 2000 units 3 times/week
- Dose adjusted based on serum testosterone levels
Injection:
- 2,000 IU
- 5,000 IU
- 10,000 IU
- Not to be used if it has any particle or discoloration
Gonadotropin; Androgen agonist
It stimulates ovarian progesterone production and testicular androgen production
- Headache
- Irritability
- Restlessness
- Depression
- Fatigue
- Edema
- Gynecomastia
- Injection site pain
- Hypersensitivity to class/components
- Pregnancy
- Precocious puberty
- Prostate cancer
- Androgen-dependent cancer
- Tranexamic acid increases thrombosis risk
Drug Status
| Availability | Prescription only |
| Pregnancy | Category X |
| Breastfeeding | Unknown |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Choriomon | 5,000 IU | Injection | 1’s | IBSA Institut | IBSA Institut |
| Hucog-5000 HP | 5,000 IU | Injection | 1’s | Bharat Serums | Nairobi Enterprises |
| Pubergen HP | 5,000 IU | Injection | 1’s | Sanzyme Ltd C/O Surgilinks | Avacare Kenya |